| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 347.36M | 441.99M | 319.81M | 262.35M | 301.17M |
| Gross Profit | 81.50M | 117.82M | 61.75M | 38.70M | 37.06M |
| EBITDA | -98.32M | -2.21B | 80.85M | -89.81M | -6.66M |
| Net Income | -407.89M | -2.22B | 55.85M | -136.77M | -60.04M |
Balance Sheet | |||||
| Total Assets | 500.27M | 596.13M | 313.66M | 238.44M | 360.47M |
| Cash, Cash Equivalents and Short-Term Investments | 40.28M | 27.68M | 162.30M | 9.21M | 15.27M |
| Total Debt | 93.74M | 129.25M | 492.94M | 461.24M | 450.57M |
| Total Liabilities | 363.77M | 385.88M | 729.76M | 709.15M | 693.37M |
| Stockholders Equity | 134.99M | 198.88M | -432.65M | -488.50M | -351.74M |
Cash Flow | |||||
| Free Cash Flow | -50.95M | -48.07M | 43.56M | -31.94M | 5.40M |
| Operating Cash Flow | -48.93M | -46.96M | 43.68M | -31.89M | 6.21M |
| Investing Cash Flow | -1.24M | 1.87M | 66.09M | 231.00K | -655.00K |
| Financing Cash Flow | 51.87M | -89.53M | 44.17M | 25.40M | -27.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$2.25B | 6.91 | 36.38% | 4.07% | 40.39% | 81.74% | |
68 Neutral | HK$36.57B | -69.15 | 11.27% | 3.18% | 26.38% | -53.61% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
51 Neutral | HK$1.50B | -3.76 | -79.55% | ― | -34.70% | -85.98% | |
46 Neutral | HK$3.03B | -7.61 | -12.57% | 0.39% | -20.46% | 19.39% | |
41 Neutral | HK$3.69B | -13.03 | -1156.74% | ― | -19.33% | 91.20% |